为您找到相关结果约500个

你是不是要搜索 期刊FGFR2+免疫 点击跳转

The frequency and somatic mutation landscape of Fibroblast growth factor receptor (FGFR) alterations

pyrazole-benzimidazole CPL304110, as a potent and selective inhibitor of fibroblast growth factor receptors FGFR

TAS-120 in patients with advanced solid tumors bearing FGF/FGFR aberrations: A Phase I study

Genome-wide CRISPR screen identifies potential therapeutic combination of EGFR and FGFR inhibitors in

Molecular mechanism of FGFR activation and resulting differences in the tumor-immune environment of bladder

FIND: A phase II study to evaluate the efficacy of erdafitinib in FGFR-altered squamous NSCLC

Comprehensive analysis of the prognostic value and immune infiltration of FGFR family members in gastric

N-Cadherin acts as a predictive biomarker for anti-FGFR therapy in KRAS wild-type NSCLC

FGFR inhibitor BGJ398 and HDAC inhibitor OBP-801 synergistically inhibit cell growth and induce apoptosis

FGFR Regulation of Dendrite Elaboration in Adult-born Granule Cells Depends on Intracellular Mediator

PD-L1 expression and FGFR-mutations among Danish patients diagnosed with metastatic urothelial carcinoma

depolymerized fragments from Costaria costata: Molecular weight and sulfation-dependent anticoagulant and FGF/FGFR

The FGFR inhibitor PD173074 binds to the C-terminus of oncofetal HMGA2 and modulates its DNA-binding

The role of fibroblast growth factor receptor (FGFR) protein-tyrosine kinase inhibitors in the treatment

Detection of Novel Activating FGFR Rearrangements, Truncations, and Splice Site Alterations in NSCLC

为您找到相关结果约500个

共500条页码: 34/34页15条/页